Article info

Download PDFPDF

Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trial

Authors

  1. a +33 144324675 christophe.letourneau{at}curie.fr
  2. b Christopher.Hoimes{at}UHhospitals.org
  3. c corrine.zarwan{at}lahey.org
  4. d DeWong{at}mednet.ucla.edu
  5. e sebastian.bauer{at}uk-essen.de
  6. f Rainer.Claus{at}klinikum-augsburg.de
  7. g Martin.Wermke{at}uniklinikum-dresden.de
  8. h s.hariharan{at}pfizer.com
  9. i Anja.von.Heydebreck{at}merckgroup.com
  10. j vijay.kasturi{at}emdserono.com
  11. k vikramkchand{at}gmail.com
  12. l gulleyj{at}mail.nih.gov
View Full Text

Citation

Le Tourneau C, Hoimes C, Zarwan C, et al
Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trial

Publication history

  • Received April 30, 2018
  • Accepted October 7, 2018
  • First published October 22, 2018.
Online issue publication 
October 22, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.